968711163	968711163	CD	B-NP	O
|	|	NNP	I-NP	O
RM	RM	NNP	I-NP	O
|	|	VBD	B-VP	O
82639332	82639332	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3093035	3093035	CD	B-NP	O
|	|	CC	I-NP	O
3/10/2005	3/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
OA	OA	NNP	I-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
knee	knee	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/21/2005	8/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/13/2005	8/13/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
GRONA	GRONA	NN	B-NP	O
,	,	,	O	O
ELIJAH	ELIJAH	NN	B-NP	O
527-52-94-0	527-52-94-0	CD	I-NP	O
Sidea	Sidea	NNP	I-NP	O
Boulevard	Boulevard	NNP	I-NP	O
,	,	,	O	O
Cholin	Cholin	NNP	B-NP	O
,	,	,	O	O
Mississippi	Mississippi	NNP	B-NP	O
16163	16163	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
ORT	ORT	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/7/05	10/7/05	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
CONTINGENT	CONTINGENT	JJ	B-NP	O
UPON	UPON	NN	I-NP	O
PT	PT	NN	I-NP	O
clearance	clearance	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CIANCIOLA	CIANCIOLA	NNP	B-NP	O
,	,	,	O	O
JAYSON	JAYSON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
300	300	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/4/05	2/4/05	CD	B-NP	O
by	by	IN	B-PP	O
ELLIFRITZ	ELLIFRITZ	NNP	B-NP	O
,	,	,	O	O
FERDINAND	FERDINAND	NNP	B-NP	O
,	,	,	O	O
PA-C	PA-C	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
CALCIUM	CALCIUM	NN	B-NP	B-protein
CARBONATE	CARBONATE	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
ELEMENTAL	ELEMENTAL	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	B-protein
500	500	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
and	and	CC	O	O
QPM	QPM	NNP	B-NP	O
MVI	MVI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/4/05	2/4/05	CD	B-NP	O
by	by	IN	B-PP	O
MCGLOTHIN	MCGLOTHIN	NN	B-NP	B-protein
,	,	,	O	O
EDWARD	EDWARD	NN	B-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
44459672	44459672	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
OXYCODONE	OXYCODONE	NNP	B-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
METAMUCIL	METAMUCIL	NNP	I-NP	O
SUGAR	SUGAR	NNP	I-NP	O
FREE	FREE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PSYLLIUM	PSYLLIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METAMUCIL	METAMUCIL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SU	SU	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NNP	B-NP	O
1	1	CD	I-NP	O
PACKET	PACKET	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
choice	choice	NN	I-NP	O
of	of	IN	B-PP	O
beverage	beverage	NN	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
dose	dose	NN	B-NP	O
for	for	IN	B-PP	O
7/2/05	7/2/05	CD	B-NP	O
4mg	4mg	NN	I-NP	O
,	,	,	O	O
dose	dose	NN	B-NP	O
for	for	IN	B-PP	O
4/12	4/12	CD	B-NP	O
and	and	CC	O	O
thereafter	thereafter	RB	B-VP	O
take	take	VB	I-VP	O
as	as	RB	I-VP	O
directed	direct	VBN	I-VP	O
by	by	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
duration	duration	NN	B-NP	O
is	be	VBZ	B-VP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Reason	Reason	NNP	B-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/4/05	2/4/05	CD	B-NP	O
by	by	IN	B-PP	O
HEFFNER	HEFFNER	NN	B-NP	O
,	,	,	O	O
QUINTIN	QUINTIN	NN	B-NP	B-protein
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
44459672	44459672	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/4/05	2/4/05	CD	B-NP	O
by	by	IN	B-PP	O
ARRELLANO	ARRELLANO	NN	B-NP	O
,	,	,	O	O
HORACIO	HORACIO	NN	B-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
12826611	12826611	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

METFORMIN	METFORMIN	NN	B-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20.0	20.0	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/14/05	6/14/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
IRON	IRON	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
weight-bearing	weight-bearing	NN	I-NP	O
:	:	:	O	O
please	please	VB	B-VP	O
increase	increase	NN	B-NP	O
ROM	ROM	NN	I-NP	O
as	as	RB	B-ADVP	O
much	much	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Wangler	Wangler	NNP	I-NP	O
,	,	,	O	O
2/20/05	2/20/05	CD	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
XRAY	XRAY	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
APT	APT	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
7/14/05	7/14/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
Monday/Thursday	Monday/Thursday	NNP	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
OIOVMC	OIOVMC	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
316.629.1453	316.629.1453	CD	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
LATEX	LATEX	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
OA	OA	NNP	B-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
knee	knee	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
OA	OA	NNP	I-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
knee	knee	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
atopic	atopic	JJ	B-NP	O
dermatitis	dermatitis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
2/4/05	2/4/05	CD	B-NP	O
BLASKO	BLASKO	NN	I-NP	O
,	,	,	O	O
QUINN	QUINN	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
RT	RT	NNP	I-NP	O
TKR	TKR	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/1/05-KUB-negative	9/1/05-KUB-negative	JJ	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
***	***	SYM	B-NP	O
Patient	Patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
elective	elective	JJ	B-NP	O
LTKA	LTKA	NN	I-NP	O
for	for	IN	B-PP	O
osteoarthritis	osteoarthritis	NN	B-NP	O
on	on	IN	B-PP	O
2/4/05	2/4/05	CD	B-NP	O
.	.	.	O	O

Procedure	Procedure	NNP	B-NP	O
went	go	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
was	be	VBD	B-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
epidural	epidural	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
received	receive	VBD	B-VP	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
RBC	RBC	NNP	B-NP	B-cell_type
's	's	POS	B-NP	O
on	on	IN	B-PP	O
DOS	DOS	NN	B-NP	B-protein
for	for	IN	B-PP	O
HCT	HCT	NN	B-NP	O
of	of	IN	B-PP	O
26	26	CD	B-NP	O
.	.	.	O	O

POD2	POD2	NN	B-NP	B-protein
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
distended	distended	JJ	I-NP	O
abdomen	abdomen	NN	I-NP	O
and	and	CC	I-NP	O
KUB	KUB	NN	I-NP	B-protein
was	be	VBD	B-VP	O
ordered	order	VBN	I-VP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ileus	ileus	NN	I-NP	O
.	.	.	O	O

POD2	POD2	NN	B-NP	B-protein
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
pain	pain	NN	I-NP	O
meds	med	NNS	I-NP	O
and	and	CC	O	O
foley	foley	JJ	B-NP	O
catheter	catheter	NN	I-NP	O
removed	remove	VBN	B-VP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	O
on	on	IN	B-PP	O
POD3	POD3	NN	B-NP	B-protein
was	be	VBD	B-VP	O
25.8	25.8	CD	B-NP	O
and	and	CC	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
clear	clear	VB	I-VP	O
PT	PT	NN	B-NP	O
protocol	protocol	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
on	on	IN	B-PP	O
POD4	POD4	NN	B-NP	B-protein
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
was	be	VBD	I-VP	O
not	not	RB	I-VP	O
dischrarged	dischrarge	VBN	I-VP	O
until	until	IN	B-PP	O
POD5	POD5	NN	B-NP	B-protein
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
5	5	CD	I-NP	I-protein
after	after	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
fluid	fluid	NN	I-NP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
1/3	1/3	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
X3	X3	NN	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
INR	INR	NNP	I-NP	O
1.5-2	1.5-2	CD	I-NP	O
.5	.5	CD	I-NP	O
,	,	,	O	O
draw	draw	JJ	B-NP	O
day	day	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
every	every	DT	B-NP	O
Monday/Thursday	Monday/Thursday	NNP	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
&	&	CC	I-NP	O
questions	question	NNS	I-NP	O
to	to	TO	B-PP	O
CHH	CHH	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
818.803.2826	818.803.2826	CD	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
wound-DSD	wound-DSD	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
OTA	OTA	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
dry	dry	JJ	B-ADJP	O
.	.	.	O	O

Remove	Remove	VB	B-VP	O
staples	staple	NNS	B-NP	O
on	on	IN	B-PP	O
8/21/05	8/21/05	CD	B-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Bradeen	Bradeen	NNP	I-NP	O
on	on	IN	B-PP	O
2/20/05	2/20/05	CD	B-NP	O
.	.	.	O	O

Weight	Weight	NN	B-NP	O
bear	bear	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
upper	upper	JJ	B-NP	O
extemity	extemity	NN	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
care	care	NN	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
draws-results	draws-result	NNS	I-NP	O
and	and	CC	I-NP	O
questions	question	NNS	I-NP	O
to	to	TO	B-PP	O
IMMC	IMMC	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
service	service	NN	I-NP	O
,	,	,	O	O
818.803.2826	818.803.2826	CD	B-NP	O
.	.	.	O	O

See	See	VB	B-VP	O
instructions	instruction	NNS	B-NP	O
for	for	IN	B-PP	O
complete	complete	JJ	B-NP	O
detail	detail	NN	I-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
care	care	NN	I-NP	O
for	for	IN	B-PP	O
wound-DSD	wound-DSD	NN	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
OTA	OTA	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
remove	remove	VB	B-VP	O
sutures	suture	NNS	B-NP	O
on	on	IN	B-PP	O
8/21/05	8/21/05	CD	B-NP	O
.	.	.	O	O

PT-weight	PT-weight	JJ	B-NP	O
bear	bear	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
upper	upper	JJ	B-NP	O
extremity	extremity	NN	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Cropp	Cropp	NNP	I-NP	O
on	on	IN	B-PP	O
2/20/05	2/20/05	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
NACCI	NACCI	NNP	B-NP	O
,	,	,	O	O
DIEGO	DIEGO	NNP	B-NP	O
L	L	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
UH673	UH673	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/7/05	10/7/05	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
38	38	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

